Analysts coverage and consensus

Analyst coverage
Below are listed the sell-side analysts that cover Givaudan on a regular basis.

Submission date Institution

Name / contact

Recommendation

03-11-2020 Baader Helvea Andreas Von Arx add
09-11-2020 Bank of America Matthew Yates buy
- Barclays Sebastian Satz sell
27-10-2020 Berenberg Bank James Targett buy
11-11-2020 Bernstein Gunther Zechmann

underperform

11-11-2020 Citi Investment Research Thomas P. Wrigglesworth neutral
26-10-2020 Credit Suisse Charles Bentley underperform
27-10-2020 Davy Research Katy Hutchinson outperform
26-10-2020 Deutsche Bank Virginie Boucher-Ferté hold
26-10-2020 EXANE BNP Paribas Heidi Vesterinen neutral
26-10-2020 Goldman Sachs International Theodora Lee Joseph sell
11-11-2020 Jefferies Ryan Tomkins underperform
05-11-2020 JP Morgan Celine Pannuti neutral
26-10-2020 Kepler Cheuvreux Patrick Roquas buy
27-10-2020 Liberum Adam Collins

buy

12-11-2020 Main First Bank AG Isha Sharma hold
04-11-2020 Mirabaud Daniel Jelovcan hold
02-11-2020 Morgan Stanley Lisa De Neve equal weight
26-10-2020 Morningstar

Rob Hales

sell
- Redburn Ranulf Orr buy
26-10-2020 Société Générale Thomas Swoboda hold
26-10-2020 UBS Charles Eden buy
26-10-2020 Vontobel Jean-Philippe Bertschy buy
28-10-2020 Zürcher Kantonalbank Daniel Buerki outperform

 

Consensus forecasts
The consensus forecasts, compiled by Givaudan, are based on emails and reports received between 26 October and 13 November 2020.

Disclaimer:
The consensus forecast set out below results from regular research reports made by analysts currently covering Givaudan, as detailed in the list below. This list has been drawn up to the best of Givaudan’s knowledge but does not purport to be comprehensive of all institutions publishing financial research on Givaudan.
Any opinions, forecasts, estimates, projections or predictions regarding Givaudan’s performance made by the analysts are exclusively theirs and do not represent the opinions, forecasts, estimates, projections or predictions of Givaudan or its management. The publication of this information on this website does not imply that Givaudan endorses, or concurs with, the reports, conclusions or recommendations of the cited analysts. Givaudan disclaims any liability for the accuracy or completeness of such information and does not assume any obligation to update it even if it becomes aware of any changes.
This information is provided for ease of reference only and does not constitute an offer or solicitation to buy, hold or sell Givaudan securities.

 

Consensus forecasts 2020 full year results
 

CHF million

  Sales

Growth
LFL %

Reported
EBITDA

Reported
net income

Free
cash flow

High

6,752

4.2

1,478

829

1,048

Average

6,383

3.7

1,396

772

831

Low

6,311

2.8

1,275

700

608

 

Consensus forecasts 2021 full year results
  

CHF million

Sales

Growth
LFL %

Reported
EBITDA

Reported
net income

Free
cash flow

High

7,179

6.0

1,539

919

1,051

Average

6,646

4.5

1,477

854

879

Low

6,355

2.8

1,293

788

631

 

Target price
  

High

Average

Low

4,800

3,666 2,250

 

Recommendations
  

Number of analysts'

recommendations

Buy

Hold

Sell

Total

9

8

5

22